Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy, safety, and pharmacokinetics of AlphaNine vs BeneFIX in severe hereditary hemophilia B
2008-002037-67Phase 2Completed
- Sponsor
- Grifols
- Start
- Jun 2008
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of coagulation factor ix in hemophilia B (HB) (2 arms), sponsored by Grifols. Primary endpoint: Pharmacokinetic profile of factor IX. Started Jun 2008; status: completed.
02
Drugs
coagulation factor ix
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on 2008-002037-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002037-67.